fda tirzepatide shortage resolved october 2 2024 declares Mounjaro, Zepbound over Lilly's weight-loss drug removed from
Description
Practically, compounded versions are made by 503A/503B compounding pharmacies (not Lilly), so the manufacturing controls, sterility testing, and dose accuracy vary by pharmacy
The data from SURMOUNT-4 offers important context
Women who are breastfeeding face additional considerations regarding medication use during lactation
Coverage varies by state and plan
The prerequisites are a stable donor area and no more active shedding
Are You Experiencing Side Effects
